Market News Video
MNV MNV 10 Stocks Crossing Below Their 200 Day Moving Average
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

IYH's Holdings Could Mean 10% Gain Potential
Friday, February 19, 7:55 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

First Week of November 19th Options Trading For Allogene Therapeutics (ALLO)
Friday, March 19, 1:57 PM ET, by Market News Video Staff

Investors in Allogene Therapeutics Inc (ALLO) saw new options become available this week, for the ...

ALLO Crosses Below Key Moving Average Level
Tuesday, March 23, 5:04 PM ET, by Market News Video Staff

In trading on Tuesday, shares of Allogene Therapeutics Inc (ALLO) crossed below their 200 day ...

First Week of ALLO June 18th Options Trading
Friday, April 16, 3:00 PM ET, by Market News Video Staff

Investors in Allogene Therapeutics Inc (ALLO) saw new options become available this week, for the ...

Allogene Therapeutics Breaks Above 200-Day Moving Average - Bullish for ALLO
Wednesday, April 21, 4:40 PM ET, by Market News Video Staff

In trading on Wednesday, shares of Allogene Therapeutics Inc (ALLO) crossed above their 200 day ...

Allogene Therapeutics Becomes Oversold (ALLO)

By Market News Video Staff, Thursday, December 31, 4:58 PM ET
Play Video: Learn About The RSI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of Allogene Therapeutics Inc (NASDAQ:ALLO) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $25.0607 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 66.8. A bullish investor could look at ALLO's 28.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of ALLO shares:

Allogene Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, ALLO's low point in its 52 week range is $17.43 per share, with $55 as the 52 week high point — that compares with a last trade of $25.24. Find out what 9 other oversold stocks you need to know about »

Special Offer: Receive our best dividend ideas directly to your inbox each afternoon with the Dividend Channel Premium Newsletter

This Article's Word Cloud:   ALLO   About   Allogene   Buffett   Channel   Dividend   Find   Index   Know   Legendary   Looking   Newsletter   Offer   Oversold   Premium   Receive   Relative   Should   Special   Start   Stocks   Strength   Therapeutics   Thursday   Warren   about   above   advises   after   afternoon   analysis   begin   below   chart   fearful   greedy   investor   look   others   oversold   point   raquo   reading   share   shares   stock   that   week   when   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

Allogene Therapeutics Becomes Oversold (ALLO) | Market News Video | Copyright © 2008 - 2022, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.